Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #43066 on RespireRx Pharmaceuticals Inc (RSPI)
BestFishes
05/24/23 11:29 PM
#43068 RE: senderos #43066
Zardiw
05/31/23 10:33 AM
#43083 RE: senderos #43066
ResolutionRx, our pharmaceutical cannabinoids subsidiary is developing compounds that target the body’s endocannabinoid system, and in particular, the re-purposing of dronabinol, an endocannabinoid CB1 and CB2 receptor agonist, for the treatment of OSA. Dronabinol is already approved by the FDA for other indications.